Bank of New York Mellon Corp Buys 4,252 Shares of InfuSystem Holdings, Inc. (NYSE:INFU)

Bank of New York Mellon Corp boosted its stake in InfuSystem Holdings, Inc. (NYSE:INFU) by 4.7% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 95,471 shares of the company’s stock after acquiring an additional 4,252 shares during the period. Bank of New York Mellon Corp owned 0.45% of InfuSystem worth $514,000 as of its most recent filing with the SEC.

Several other hedge funds have also added to or reduced their stakes in INFU. Nuveen Asset Management LLC raised its position in shares of InfuSystem by 14.1% in the fourth quarter. Nuveen Asset Management LLC now owns 86,379 shares of the company’s stock valued at $730,000 after purchasing an additional 10,647 shares during the period. BNP Paribas Financial Markets raised its position in shares of InfuSystem by 67.9% in the fourth quarter. BNP Paribas Financial Markets now owns 6,844 shares of the company’s stock valued at $58,000 after purchasing an additional 2,768 shares during the period. Deutsche Bank AG raised its position in shares of InfuSystem by 148.3% in the fourth quarter. Deutsche Bank AG now owns 27,671 shares of the company’s stock valued at $234,000 after purchasing an additional 16,526 shares during the period. Two Sigma Investments LP raised its position in shares of InfuSystem by 40.4% in the fourth quarter. Two Sigma Investments LP now owns 36,252 shares of the company’s stock valued at $306,000 after purchasing an additional 10,427 shares during the period. Finally, Northern Trust Corp raised its position in shares of InfuSystem by 7.7% in the fourth quarter. Northern Trust Corp now owns 186,741 shares of the company’s stock valued at $1,578,000 after purchasing an additional 13,333 shares during the period. Institutional investors own 71.13% of the company’s stock.

InfuSystem Price Performance

Shares of NYSE:INFU opened at $5.70 on Monday. The company has a 50 day moving average of $5.94 and a 200 day moving average of $6.18. The stock has a market cap of $119.79 million, a P/E ratio of 95.02 and a beta of 1.81. InfuSystem Holdings, Inc. has a 12 month low of $4.61 and a 12 month high of $9.97. The company has a current ratio of 1.98, a quick ratio of 1.59 and a debt-to-equity ratio of 0.50.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on the stock. B. Riley raised shares of InfuSystem to a “strong-buy” rating in a research report on Thursday, May 8th. Roth Capital began coverage on shares of InfuSystem in a research note on Tuesday, July 22nd. They set a “buy” rating and a $12.00 price objective for the company. Finally, Wall Street Zen cut shares of InfuSystem from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, May 14th.

About InfuSystem

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.